
John D. Lee
Examiner (ID: 7564)
| Most Active Art Unit | 2501 |
| Art Unit(s) | 2501, 3621, 2874, 2606, 2504, 2507 |
| Total Applications | 2783 |
| Issued Applications | 2467 |
| Pending Applications | 118 |
| Abandoned Applications | 198 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8405464
[patent_doc_number] => 20120237517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-20
[patent_title] => 'Antibody Substituting for Function of Blood Coagulation Factor VIII'
[patent_app_type] => utility
[patent_app_number] => 13/434643
[patent_app_country] => US
[patent_app_date] => 2012-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 28766
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13434643
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/434643 | Antibody Substituting for Function of Blood Coagulation Factor VIII | Mar 28, 2012 | Abandoned |
Array
(
[id] => 9691282
[patent_doc_number] => 08821871
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-02
[patent_title] => 'Anticoagulant antidotes comprising antibodies that bind dabigatran and/or related compounds and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 13/432296
[patent_app_country] => US
[patent_app_date] => 2012-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 20281
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13432296
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/432296 | Anticoagulant antidotes comprising antibodies that bind dabigatran and/or related compounds and methods of use thereof | Mar 27, 2012 | Issued |
Array
(
[id] => 8720179
[patent_doc_number] => 20130071396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-21
[patent_title] => 'METHOD OF INHIBITING COAGULATION ACTIVATION WITH HUMAN ANTI-FACTOR V ANTIBODIES AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/428611
[patent_app_country] => US
[patent_app_date] => 2012-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11723
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13428611
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/428611 | METHOD OF INHIBITING COAGULATION ACTIVATION WITH HUMAN ANTI-FACTOR V ANTIBODIES AND USE THEREOF | Mar 22, 2012 | Abandoned |
Array
(
[id] => 10002451
[patent_doc_number] => 09046535
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-02
[patent_title] => 'Methods and kits for measuring von willebrand factor'
[patent_app_type] => utility
[patent_app_number] => 13/421217
[patent_app_country] => US
[patent_app_date] => 2012-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 6
[patent_no_of_words] => 11148
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13421217
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/421217 | Methods and kits for measuring von willebrand factor | Mar 14, 2012 | Issued |
Array
(
[id] => 8264732
[patent_doc_number] => 20120164165
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-28
[patent_title] => 'ZONA PELLUCIDA BINDING PEPTIDES, EXPRESSION VECTORS, COMPOSITIONS, AND METHODS FOR SPECIES-SPECIFIC IMMUNOCONTRACEPTION OF ANIMALS'
[patent_app_type] => utility
[patent_app_number] => 13/416348
[patent_app_country] => US
[patent_app_date] => 2012-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8963
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13416348
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/416348 | Zona pellucida binding peptides for species specific immunocontraception of animals | Mar 8, 2012 | Issued |
Array
(
[id] => 8846260
[patent_doc_number] => 08455441
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-04
[patent_title] => 'Antidotes for factor Xa inhibitors and methods of using the same'
[patent_app_type] => utility
[patent_app_number] => 13/414499
[patent_app_country] => US
[patent_app_date] => 2012-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 24
[patent_no_of_words] => 36373
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13414499
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/414499 | Antidotes for factor Xa inhibitors and methods of using the same | Mar 6, 2012 | Issued |
Array
(
[id] => 9134846
[patent_doc_number] => 20130295561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-07
[patent_title] => 'Methods of enriching fetal cells'
[patent_app_type] => utility
[patent_app_number] => 13/385775
[patent_app_country] => US
[patent_app_date] => 2012-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 17058
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13385775
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/385775 | Methods of enriching fetal cells | Mar 5, 2012 | Abandoned |
Array
(
[id] => 8323491
[patent_doc_number] => 20120195902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-02
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING RENAL DISEASE'
[patent_app_type] => utility
[patent_app_number] => 13/404725
[patent_app_country] => US
[patent_app_date] => 2012-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 25081
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13404725
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/404725 | Compositions and methods for treating renal disease | Feb 23, 2012 | Issued |
Array
(
[id] => 10621836
[patent_doc_number] => 09340773
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-17
[patent_title] => 'Antigen-presenting platelets and methods of eliciting an immune response'
[patent_app_type] => utility
[patent_app_number] => 14/000959
[patent_app_country] => US
[patent_app_date] => 2012-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 37
[patent_no_of_words] => 7499
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14000959
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/000959 | Antigen-presenting platelets and methods of eliciting an immune response | Feb 21, 2012 | Issued |
Array
(
[id] => 9468415
[patent_doc_number] => 08722044
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-13
[patent_title] => 'Human tissue factor antibody and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/398881
[patent_app_country] => US
[patent_app_date] => 2012-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 21734
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13398881
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/398881 | Human tissue factor antibody and uses thereof | Feb 16, 2012 | Issued |
Array
(
[id] => 9510945
[patent_doc_number] => 20140147437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-29
[patent_title] => 'METHODS TO ENHANCE CELL-MEDIATED IMMUNITY'
[patent_app_type] => utility
[patent_app_number] => 13/985697
[patent_app_country] => US
[patent_app_date] => 2012-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 27080
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13985697
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/985697 | METHODS TO ENHANCE CELL-MEDIATED IMMUNITY | Feb 15, 2012 | Abandoned |
Array
(
[id] => 9413043
[patent_doc_number] => 08697079
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-15
[patent_title] => 'IgE antibodies for the treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 13/372557
[patent_app_country] => US
[patent_app_date] => 2012-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15449
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13372557
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/372557 | IgE antibodies for the treatment of cancer | Feb 13, 2012 | Issued |
Array
(
[id] => 8227259
[patent_doc_number] => 20120141463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-07
[patent_title] => 'Method Of Identifying Membrane Ig Specific Antibodies And Use Thereof For Targeting Immunoglobulin-Producing Precursor Cells'
[patent_app_type] => utility
[patent_app_number] => 13/372170
[patent_app_country] => US
[patent_app_date] => 2012-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 32814
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13372170
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/372170 | Method of identifying membrane Ig specific antibodies and use thereof for targeting immunoglobulin-producing precursor cells | Feb 12, 2012 | Issued |
Array
(
[id] => 8312609
[patent_doc_number] => 20120189632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-26
[patent_title] => 'METHOD FOR EXTENDING PREGNANCY IN PATIENTS EXHIBITING AT LEAST ONE SYMPTOM OF PREECLAMPSIA AND ECLAMPSIA'
[patent_app_type] => utility
[patent_app_number] => 13/372151
[patent_app_country] => US
[patent_app_date] => 2012-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 28510
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13372151
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/372151 | Method for extending pregnancy by reducing intraventricular hemorrhaging in patients exhibiting at least one symptom of preeclampsia and eclampsia | Feb 12, 2012 | Issued |
Array
(
[id] => 9602621
[patent_doc_number] => 20140199302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-17
[patent_title] => 'COMPOSITIONS FOR REGULATING IRON HOMEOSTASIS AND METHODS OF USING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/980666
[patent_app_country] => US
[patent_app_date] => 2012-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 16746
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13980666
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/980666 | Compositions for regulating iron homeostasis and methods of using same | Jan 18, 2012 | Issued |
Array
(
[id] => 9318405
[patent_doc_number] => 20140050743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-20
[patent_title] => 'BINDING PROTEINS TO INHIBITORS OF COAGULATION FACTORS'
[patent_app_type] => utility
[patent_app_number] => 13/980431
[patent_app_country] => US
[patent_app_date] => 2012-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 39159
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13980431
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/980431 | BINDING PROTEINS TO INHIBITORS OF COAGULATION FACTORS | Jan 16, 2012 | Abandoned |
Array
(
[id] => 8265783
[patent_doc_number] => 20120165211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-28
[patent_title] => 'Human Antibodies Cross-Reacting With A Bacterial And A Self Antigen From Atherosclerotic Plaques'
[patent_app_type] => utility
[patent_app_number] => 13/350527
[patent_app_country] => US
[patent_app_date] => 2012-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 257
[patent_figures_cnt] => 257
[patent_no_of_words] => 35952
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13350527
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/350527 | Human Antibodies Cross-Reacting With A Bacterial And A Self Antigen From Atherosclerotic Plaques | Jan 12, 2012 | Abandoned |
Array
(
[id] => 8239832
[patent_doc_number] => 20120148566
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-14
[patent_title] => 'PRODUCT AND METHOD FOR TREATMENT OF CONDITIONS ASSOCIATED WITH RECEPTOR-DESENSITIZATION'
[patent_app_type] => utility
[patent_app_number] => 13/349764
[patent_app_country] => US
[patent_app_date] => 2012-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 21960
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13349764
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/349764 | PRODUCT AND METHOD FOR TREATMENT OF CONDITIONS ASSOCIATED WITH RECEPTOR-DESENSITIZATION | Jan 12, 2012 | Abandoned |
Array
(
[id] => 8239950
[patent_doc_number] => 20120148688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-14
[patent_title] => 'PREVENTION OF THROMBUS FORMATION AND/OR STABILIZATION'
[patent_app_type] => utility
[patent_app_number] => 13/339793
[patent_app_country] => US
[patent_app_date] => 2011-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9346
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13339793
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/339793 | PREVENTION OF THROMBUS FORMATION AND/OR STABILIZATION | Dec 28, 2011 | Abandoned |
Array
(
[id] => 8300974
[patent_doc_number] => 20120183534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-19
[patent_title] => 'METHODS, COMPOSITIONS AND APPARATUSES FOR FACILITATING REGENERATION'
[patent_app_type] => utility
[patent_app_number] => 13/332976
[patent_app_country] => US
[patent_app_date] => 2011-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2975
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13332976
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/332976 | Methods, compositions and apparatuses for facilitating regeneration | Dec 20, 2011 | Issued |